Glutathione S-Transferase θ1 polymorphism contributes to lung cancer susceptibility: A Meta-Analysis of 26 case-control studies

Oncology Letters

Volumn 9, Issue 4, 2015, Pages 1947-1953

  Zhao, Yan ^a   Wang, Bingwei ^a   Hu, Kai ^b   Wang, Juan ^a   Lu, Su ^c   Zhang, Yanxi ^a   Lu, Weiquan ^a   Zhao, Erjiang ^a   Yuan, Ling ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Academy of Medical Sciences   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Glutathione S transferase 1; Lung cancer; Meta analysis; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE T1;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DATA EXTRACTION; DISEASE ASSOCIATION; GENE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; GLUTATHIONE TRANSFERASE T1 GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; META ANALYSIS; NEWCASTLE-OTTAWA SCALE; QUALITY CONTROL; SCORING SYSTEM; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA;

EID: 84923197125     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.2948     Document Type: Article

References (65)

1. Dialyna IA, Miyakis S, Georgatou N and Spandidos DA: Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol Rep 10: 1829-1835, 2003.
2. Yang X, Qiu MT, Hu JW, et al: GSTT1 null genotype contributes to lung cancer risk in Asian populations: a meta-analysis of 23 studies. PLoS One 8: e62181, 2013.
3. Litwack G, Ketterer B and Arias IM: Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature 234: 466-467, 1971.
4. Gallegos-Arreola MP, Gómez-Meda BC, Morgan-Villela G, et al: GSTT1 gene deletion is associated with lung cancer in Mexican patients. Dis Markers 19: 259-261, 2004.
5. Wang J, Deng Y, Cheng J, Ding J and Tokudome S: GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 201: 185-193, 2003.
6. Salagovic J, Kalina I, Stubna J, et al: Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 45: 312-317, 1998.
7. Zhong S, Howie AF, Ketterer B, et al: Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12: 1533-1537, 1991.
8. Sprenger R, Schlagenhaufer R, Kerb R, et al: Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10: 557-565, 2000.
9. Hayashi S, Watanabe J and Kawajiri K: High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83: 866-870, 1992.
10. Hirvonen A, Husgafvel-Pursiainen K, Anttila S and Vainio H: The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479-1481, 1993.
11. Alexandrie AK, Sundberg MI, Seidegård J, et al: Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15: 1785-1790, 1994.
12. Houlston RS: Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 8: 675-682, 1999
13. London SJ, Daly AK, Cooper J, et al: Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 87: 1246-1253, 1995.
14. Saarikoski ST, Voho A, Reinikainen M, et al: Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77: 516-521, 1998.
15. Kiyohara C, Horiuchi T, Takayama K and Nakanishi Y: Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 7: 954-962, 2012.
16. Tamaki Y, Arai T, Sugimura H, et al: Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metab Pharmacokinet 26: 516-522, 2011.
17. Piao JM, Shin MH, Kim HN, et al: Glutathione-S-transferase (GSTM1, GSTT1) null phenotypes and risk of lung cancer in a Korean population. Asian Pac J Cancer Prev 14: 7165-7169, 2013.
18. Shaikh RS, Amir M, Masood AI, et al: Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence. Environ Toxicol Pharmacol 30: 76-79, 2010.
19. Chan-Yeung M, Tan-Un KC, Ip MS, et al: Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 45: 155-160, 2004.
20. Chen HC, Cao YF, Hu WX, et al: Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis Markers 22: 141-152, 2006.
21. Kiyohara C, Yamamura KI, Nakanishi Y, et al: Polymorphism in GSTM1, GSTT1 and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev 1: 293-298, 2000.
22. Lan Q, He X, Costa DJ, et al: Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev 9: 605-608, 2000.
23. Lee KM, Kang D, Lee SJ, et al: Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 16: 1035-1039, 2006.
24. London SJ, Yuan JM, Chung FL, et al: Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356: 724-729, 2000.
25. Yang M, Choi Y, Hwangbo B, et al: Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57: 135-142, 2007.
26. Wang J, Deng Y, Cheng J, et al: GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 201: 185-193, 2003.
27. Wang N, Wu Y, Zhou X and Wu Y: Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population. Wei Sheng Yan Jiu 41: 251-256, 2012 (In Chinese).
28. Yuan T, Zhou Q, Zhu W, et al: Relationship between genetic polymorphism of GSTT1 gene and inherent susceptibility to lung cancer in Han population in Sichuan, China. Zhongguo Fei Ai Za Zhi 8: 107-111, 2005 (In Chinese).
29. Bai TY: The study on the polymorphisms of GSTM1, GSTM3, GSTT1, GSTP1 genes and susceptibility to lung cancer in Mongolian population. PhD dissertation, Inner Mongolia Medical College, Inner Mongolia, pp15-18, 2011 (In Chinese).
30. Li YF: A case-control study on the associations between polymorphism of GSTM1, GSTT1 and susceptibility to breast cancer and lung cancer. PhD dissertation, Sichuan University, Sichuan, pp26-33, 2007 (In Chinese).
31. Du GB: A study on relationship between genetic polymorphism of GSTM1 and GSTT1 gene and susceptibility to lung cancer in the population of northern Sichuan of China. PhD dissertation, North Sichuan Medical University, Sichuan, pp18-25, 2011 (In Chinese).
32. Wang N: The relationship between the deletion of GSTM1, GSTT1 and susceptibility to lung cancer. PhD dissertation, Zhengzhou University, Zhengzhou, pp18-26, 2003 (In Chinese).
33. Fan J: Study on the polymorphisms of GSTM1 and GSTT1 genes associated with susceptibility to lung cancer. PhD dissertation, GuangXi Medical University, GuangXi, pp15-24, 2011 (In Chinese).
34. Liu JN: Study on the relationship between the genetic polymorphism of GSTT1 gene, smoking and lung cancer susceptibility. PhD dissertation, Yanbian University, Yanbian, pp8-12, 2009 (In Chinese).
35. He DX and Tang Y: The relationship of GSTT1 polymorphism and chromosome 15 aberration in lung cancer patients. Zhong Liu Fang Zhi Yan Jiu 33: 308-310, 2006 (In Chinese).
36. Qi XS, Lv HM, Xia Y, et al: A primary case-control study on the relationship between genetic polymorphisms of GSTT1 and lung cancer susceptibility to the people living in high radon-exposed area. Zhong Guo Zhi Ye Yi Xue 31: 361-367, 2008 (In Chinese).
37. Lan Q, He XZ, Costa D, et al: Glutathione S-transferase GSTM1 and GSTT1 genotypes and susceptibility to lung cancer. Wei Sheng Yan Jiu 28: 9-11, 1999.
38. Zhang JK: Genetic polymorphisms of glutathione S-transferase M1 and T1 gene related with the susceptibility to lung cancer. PhD dissertation, Jinan University, Guangzhou, pp25-32, 2002 (In Chinese).
39. Fan J, Gan LZ, Liang KC and Liang XM: Relationship of GSTM1 and GSTT1 genetic polymorphisms with lung cancer susceptibility in Guangxi Zhuang population. Zhong Liu Xue Za Zhi 16: 922-925, 2010 (In Chinese).
40. Cao YF, Chen HC, Liu XF, et al: Study on the relationship between the genetic polymorphisma of GSTM1 and GSTT1 genes and lung cancer susceptibility in the population of Hunan province of China. Life Sci Res 8: 126-132. 2004 (In Chinese).
41. Liang KC, Gan LK, Ruan L, et al: Correlational research of the relationship between the genetic polymorphism of GSTM1 and GSTT1 in the Zhuang population and lung cancer. Acta Med Sinica 25: 813-817, 2012 (In Chinese).
42. Wells GA, Shea B, O'Connell D, et al; Ottawa Hospital Research Institute: The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Oct 19, 2009.
43. Lau J, Ioannidis JP and Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826, 1997.
44. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
45. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
46. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
47. Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743, 1997.
48. Deakin M, Elder J, Hendrickse C, et al: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17: 881-884, 1996.
49. Sunaga N, Kohno T, Yanagitani N, et al: Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11: 730-738, 2002.
50. Harms C, Salama SA, Sierra-Torres CH, et al: Polymorphisms in DNA repair genes, chromosome aberrations and lung cancer. Environ Mol Mutagen 44: 74-82, 2004.
51. Stücker I, Hirvonen A, de Waziers I, et al: Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 23: 1475-1481, 2002.
52. Yang P, Bamlet WR, Ebbert JO, et al: Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 25: 1935-1944, 2004.
53. Cabral RE, Caldeira-de-Araujo A, Cabral-Neto JB and Costa Carvalho Mda G: Analysis of GSTM1 and GSTT1 polymorphisms in circulating plasma DNA of lung cancer patients. Mol Cell Biochem 338: 263-269, 2010.
54. Sreeja L, Syamala V, Hariharan S, et al: Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50: 618-627, 2005.
55. Langevin SM, Ioannidis JP, Vineis P and Taioli E; Genetic Susceptibility to Environmental Carcinogens group (GSEC): Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenet Genomics 20: 586-597, 2010.
56. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, et al: Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164: 1027-1042, 2006.
57. Wang Y, Yang H, Li L and Wang H: Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: a meta-analysis. Cancer Epidemiol 34: 593-597, 2010.
58. Nelson HH, Wiencke JK, Christiani DC, et al: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16: 1243-1245, 1995.
59. Zhong S, Howie AF, Ketterer B, et al: Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12: 1533-1537, 1991.
60. Spitz MR, Duphorne CM, Detry MA, et al: Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 1017-1020, 2000.
61. Hou SM, Fält S and Nyberg F: Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environ Mol Mutagen 38: 83-86, 2001.
62. Spitz MR, Wei Q, Dong Q, et al: Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698, 2003.
63. Honma HN, De Capitani EM, Perroud MW, et al: Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 61: 152-162, 2008.
64. Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, et al: Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 10: 1063-1067, 2001.
65. Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, Zaridze D Jr, et al: Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 366: 1558-1560, 2005.